1.41
Filana Therapeutics Inc Aktie (FLNA) Neueste Nachrichten
Filana Therapeutics (FLNA) Posts Modest Gains Amid Broader Biotech ResilienceExpert Breakout Alerts - Newser
FLNA Should I Buy - Intellectia AI
Filana Therapeutics (FLNA) Stock: Up +0.80%, Key Resistance at $1.32 2026-05-21Community Trade Ideas - Newser
FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
FLNA Stock Price, Quote & Chart | FILANA THERAPEUTICS INC (NASDAQ:FLNA) - ChartMill
MSN Money - MSN
Filana Therapeutics 1Q Loss/Shr 21c >FLNA - Moomoo
Filana Therapeutics (NASDAQ: FLNA) trims Q1 2026 loss, pivots simufilam to TSC epilepsy - Stock Titan
Filana Therapeutics Releases Q1 2026 Financial Results and Business Update on May 7, 2026 - geneonline.com
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update - The Manila Times
Cost cuts shrink Filana Therapeutics (NASDAQ: FLNA) Q1 2026 net loss - Stock Titan
Biotech with $86.6M cash says FDA hold keeps epilepsy trial on hold - Stock Titan
Cassava Sciences | 8-K: Current report - Moomoo
At a Madrid epilepsy meeting, Filana detailed why it’s testing simufilam - Stock Titan
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII - GlobeNewswire
MSN - MSN
[ARS] FILANA THERAPEUTICS, INC. SEC Filing - Stock Titan
Filana Therapeutics (FLNA) details 2026 meeting and equity plan vote - Stock Titan
Filana Therapeutics (FLNA) director O’Donnell to leave board after 2026 meeting - Stock Titan
How does Filana Therapeutics (FLNA) make money? (Market Focus) 2026-04-27Senior Analyst Forecasts - newser.com
Cassava Sciences (FLNA) Stock Price, News & Analysis $FLNA - MarketBeat
FLNA Filana Therapeutics posts narrower than expected Q3 2025 loss, shares edge higher in today’s trading.Trade Idea Marketplace - Newser
Is Filana Therapeutics (FLNA) stock appealing for long-term investors (Slight Rise) 2026-04-20Continuation Pattern - Xã Châu Thành
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):